US6344541B1 - DKR polypeptides - Google Patents

DKR polypeptides Download PDF

Info

Publication number
US6344541B1
US6344541B1 US09/161,241 US16124198A US6344541B1 US 6344541 B1 US6344541 B1 US 6344541B1 US 16124198 A US16124198 A US 16124198A US 6344541 B1 US6344541 B1 US 6344541B1
Authority
US
United States
Prior art keywords
dkr
polypeptide
gly
human
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US09/161,241
Inventor
Michael Brian Bass
John Kevin Sullivan
Lars Eyde Theill
Daguang Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Priority to US09/161,241 priority Critical patent/US6344541B1/en
Assigned to AMGEN INC. reassignment AMGEN INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BASS, MICHAEL BRIAN, SULLIVAN, JOHN KEVIN, THEILL, LARS EYDE, WANG, DAGUANG
Application granted granted Critical
Publication of US6344541B1 publication Critical patent/US6344541B1/en
Anticipated expiration legal-status Critical
Application status is Expired - Lifetime legal-status Critical

Links